Members of CAE visited the president at Casa Rosada after demanding that the PCT that is about to vote in Deputies should not be changed, as demanded by the national laboratories. The official says that the delay is imposed by Washington. The companies announced an investment of $8 billion in clinical research.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Members of CAE visited the president at Casa Rosada after demanding that the PCT that is about to vote in Deputies should not be changed, as demanded by the national laboratories. The official says that the delay is imposed by Washington. The companies announced an investment of $8 billion in clinical research.